Dear colleagues,

The National Diabetes Programme is holding a one-day Diabetes Technology Networking Event in the Sheraton Athlone on Thursday 10th October 2024. It is aimed at multidisciplinary specialist acute care diabetes teams across Ireland who want to upskill, increase confidence and maintain competence in incorporating diabetes technology and e-health into their diabetes care pathways.

Registration for the event is now open. Please find the link below for the registration form as well as the final programme for the event. 

NDP Technology Networking Event Programme Oct 10th 2024 Final

NDP Diabetes Tech Study Day Registration Form 10th Oct 2024

Dear Colleagues,

I trust you all had a relaxing and enjoyable summer. The Joint Irish-UK Endocrine Meeting is fast approaching (just over five weeks to go!) and we are very much looking forward to welcoming you to Belfast! Registration is open link 

**Registration for the Gala Dinner has just opened.**  This will take place in the beautiful surroundings of Belfast City Hall and promises to be a fantastic evening with a drinks reception, fine dining and entertainment provided.  Entrance is by ticket only and this MUST be purchased online in advance of the meeting and it is not possible to register on the day.  I would urge you to register asap- this is definitely an event not to be missed! (Please note, if you have already registered for the conference, this does not include registration for the gala dinner and you must follow the instructions in the link below to add tickets for the dinner to your registration)

Please find the link for further info on how to get your tickets. Joint Irish-UK Endocrine Meeting 2024 – Conference dinner | Society for Endocrinology

If you have not registered for the conference yet, this can be done online using the link Registration | Society for Endocrinology

Finally- if you have not booked accommodation yet, the IES have secured a preferential rate at the Grand Central Hotel in Belfast of £155 B&B per night single occupancy, £175 B&B per night double occupancy on Sun 13th and Mon 14th October (limited availability- must be booked before 16^th September).  If you would like to book, please call 028 9023 1066 or email [email protected] quoting Irish Endocrine Society and the block ID number 658331.  The hotel is close to the bus and train stations and has car parking nearby.  It is within walking distance of the city centre, the conference centre and the location for the conference dinner.

I hope this information is helpful and very much look forward to catching up with you all in Belfast.

Best wishes,

Helen

Dear Colleagues

Please find the link below for the Society for Endocrinology upcoming event on Endocrine Genetic Testing, which will be held on 26th September 2024 in Birmingham, UK.
Endocrine Genetic Testing 2024 | Society for Endocrinology

This one-day training event will equip attendees with essential skills in using the new national Genomic Laboratory Hubs, and will provide the opportunity to form collaborative networks with fellow  specialist clinicians to help improve patient diagnosis and care.  This training event will appeal to Consultants, Clinical Geneticists and trainees working in paediatric and adult endocrinology.

It is with great sadness we announce the death of Prof. TJ McKenna 3rd May 2024  He was a founding member of the Irish Endocrine Society and a past president of the Irish Endocrine Society. Joe remained an active member and a regular contributor and attender at the meetings. He was also a past president of the Royal College of Physicians of Ireland. He will be sadly missed by the members of the Irish Endocrine Society. On behalf the membership of the Irish Endocrine Society, we would like to extend our sincerest condolences to Prof. McKenna’s family, friends and colleagues.

Prof. TJ McKenna pictured at Study Day 2019

Dear Colleagues

Please find the attached February edition of the Diabetes Collaborative Clinical Trial Network, which is packed with exciting updates and upcoming grant and funding opportunities. This newsletter is your key to staying informed and engaged with the Diabetes Collaborative Clinical Trial Network.

DCCTN February 2024 Newsletter

You can also find it by clicking here. 

HRB DC-CTN • An all island collaborative network (diabetestrialsctn.ie)

On the International Women’s Day, the Irish Endocrine Society Committee would like to extend our heartfelt congratulations to Professor Fidelma Dunne, the President of Irish Endocrine Society, on having been selected as the recipient of the American Diabetes Association’s 2024 Norbert Freinkel Award. The Nobert Freinkel Award is presented to a researcher who has made outstanding scientific contributions to the understanding and treatment of diabetes and pregnancy. The American Diabetes Association’s 84th Scientific Sessions will be held on June 21 to 24, 2024 in Orlando, Florida. The Norbert Freinkel Award Lecture will be presented on Sunday, June 23, 2024 from 1:30 p.m. to 2:00 p.m.

Comment from Professor Fidelma Dunne on being selected as the recipient of the ADA’s 2024 Norbert Freinkel Award  “I am thrilled to receive this award on behalf of Irish Endocrinology. It is timely to acknowledge the long standing working relationship and research collaboration with many members of the society around the country which has contributed to this award. In particular I wish to extend my appreciation to all the Endocrine trainees over the last 20 years who have worked on and published research findings in DiP. Lastly my work in Diabetes in Pregnancy has only been possible through the support of skilled colleagues in the Institute of Clinical Trials at the University of Galway, Galway University Hospital and the Saolta Hospital group.”

Dear Colleagues

The National Clinical Programme for Diabetes invite you to a webinar to highlight and launch a number of updated and newly published documents on Wednesday 28th February 2024 11.00-13.0.

Documents include:
– Diabetes in Pregnancy: A Model of Care for Ireland (2024)
– Sick Day Advice Leaflets
– Insulin Titration guidelines for Nurses & Midwives working with people with Diabetes
– National Diabetes Prevention Programme Report
– DISCOVER Type 2 Diabetes Report
– Language Matters Document (in collaboration with Diabetes Ireland)
– Survey Report: Transition of care of Adolescents/Young Adults with Type 1 Diabetes Mellitus from paediatric to adult outpatient services

Speakers:
 Minister for Health
 National Clinical Advisor Chronic Disease Dr. Sarah O’Brien
 Prof Fidelma Dunne (President of IES)
 Prof Mary Higgins
 Clinical Lead Prof O’Keeffe
 Prof Sean Dinneen
 Pw Diabetes
 AMP Ms. Ciara Coveney
 Nursing & HSCP NCP Diabetes leads
 Self-Management Education team

Please find the registration link below: 

Webinar registration invite Diabetes NCP 28022024

It is with great sadness we announce the death of Prof. Barry Ferriss on 24th February 2024. He was awarded the Lifetime Achievement Award by the Irish Endocrine Society in 2018. He also gave the Nordisk lecture in 1986. Barry remained an active member, a regular contributor and an attendee at the meetings throughout his career. He will be sadly missed. On behalf the membership of the Irish Endocrine Society, we would like to extend our sincerest condolences to Harriett, his family, friends and colleagues.

Dear IES Members and Affiliates

DCTN January 2024 Newsletter

Professor Fidelma Dunne appointed Interim Director and

John Kilmartin as Adjunct Professor

Photo Martina Regan

Tuesday January 30, 2024: World-leading research academic Professor Fidelma Dunne has been appointed Interim Director of the Institute for Clinical Trials at University of Galway.

Professor Dunne has an extensive background in clinical trial management and is ranked number 1 in Ireland and number 6 in the world for her research into gestational diabetes.

The University has also announced John Kilmartin, former Vice-President of Regulatory Affairs at Medtronic and an independent medtech regulatory expert, joins the Institute for Clinical Trials as Adjunct Professor.

Mr Kilmartin has more than 30 years’ experience in the medtech industry, with a particular focus on the emerging regulatory and clinical frameworks in Europe.

Professor Martin O’Donnell, Dean of the College of Medicine, Nursing and Health Sciences and Consultant Geriatrician at Saolta University Health Care Group, said: “We are honoured to have both Professor Fidelma Dunne and Mr John Kilmartin join the Institute for Clinical Trials. Their combined expertise in clinical trials, medical research and regulatory affairs will significantly contribute to our mission of advancing impactful clinical research. They will help to advance our clinical research goals and will make meaningful contributions to healthcare outcomes.”

Professor Dunne said: “Clinical trials in new medicines and devices are vital to improving the health of people living in Ireland and worldwide. Improving health also has economic and societal benefits. Engaging in clinical trials allows patients in Ireland to receive new medicines and devices early. We have a track record of designing and delivering impactful clinical trials at University of Galway and I am delighted to lead the Institute for Clinical Trials which will have a pivotal role in further enhancing the clinical research landscape in Ireland.”

Mr Kilmartin said: “The medtech industry is of huge importance to Ireland and Europe for the benefit of our patients, health systems and society. I believe that the Institute for Clinical Trials at University of Galway can play a key role in helping to support innovation in medtech by strategically targeting barriers within the Irish ecosystem. It aims to strengthen and further promote growth in the medtech sector, expand treatment options for patients and ultimately contribute to the advancement of healthcare on a broader scale.”

Bios

Professor Fidelma Dunne is the immediate past President of the International Association Diabetes in Pregnancy Study Groups and President of the Irish Endocrine Society (2021-2024). Professor Dunne has demonstrated an unwavering commitment to advancing research and improving outcomes in the critical area of diabetes and pregnancy.

Her research interests, focused on diabetes and pregnancy, have resulted in an impressive portfolio of over 240 peer-reviewed publications, 12,000 citations, and significant grant funding.

Professor Dunne was honoured with the Jorgen Pedersen award in 2021 for her exceptional work in Diabetes in Pregnancy. She is the Principal Investigator of the EMERGE randomised controlled trial, funded by the Health Research Board, with ground-breaking results published in the Journal of American Medical Association (JAMA) in October 2023 which showed that the drug metformin provided a safe and effective way to treat gestational diabetes.

John Kilmartin has a wealth of experience and knowledge in the medtech industry, having led global regulatory teams in the development and implementation of clinical and regulatory strategies for various medical devices and drug/device combination products.

He is actively involved with various medtech industry associations, including MedTech Europe and the Irish MedTech Association (IMA), where he served as the Chair of the IMA Regulatory Steering Committee for a number of years.

Mr Kilmartin has a strong focus on the evolving regulatory and clinical frameworks around the world, having collaborated with regulatory agencies such as FDA, European Notified Bodies, Competent authorities and other international regulators.

Mr Kilmartin’s areas of interest and focus include the development of the next generation of Regulatory and Clinical Affairs professionals, creating co-operative links between third-level institutions, the medtech industry, regulatory authorities, and government agencies to ensure that the medtech ecosystem continues to thrive in Ireland and in Europe.

Original article: University of Galway – College of Medicine, Nursing and Health Sciences on LinkedIn: NEWS: Two senior appointments announced for the Institute for Clinical… | 22 comments